Zobrazeno 1 - 10
of 231
pro vyhledávání: '"LL Lee"'
Autor:
Haeri Choi, Sung Chun Cho, Young Wan Ha, Billie Ocampo, Shirley Park, Shiwen Chen, Christopher F. Bennett, Jeehae Han, Ryan Rossner, Jong-Sun Kang, Yun-ll Lee, Sang Chul Park, Matt Kaeberlein
Publikováno v:
Translational Medicine of Aging, Vol 3, Iss , Pp 64-69 (2019)
The antibiotic diaminodiphenyl sulfone (DDS) is used in combination with other antibiotics as a first line treatment for leprosy. DDS has been previously reported to extend lifespan in Caenorhabditis elegans through inhibition of pyruvate kinase and
Externí odkaz:
https://doaj.org/article/703a38fb11dc4f9488f12d04f06a6285
Publikováno v:
Archives of Clinical and Medical Case Reports.
Publikováno v:
Biological Research, Vol 43, Iss 2, Pp 225-231 (2010)
Objectives: The objective of this study is to determine the effects of Ethyl acetate fraction from Cudrania tricuspidata (EACT) on the interleukin-1b (IL-1b)-induced proliferation of rheumatoid synovial fbroblasts (RASFs) and production of matrix met
Externí odkaz:
https://doaj.org/article/f2147c8acb3041979868fd894f872ed9
Autor:
Erin Yoder, P Baron, Lisa Blumencranz, Thomas Lomis, Adam Brufsky, Gordan Srkalovic, Sarah Untch, Jennifer A. Crozier, Peter W. Blumencranz, P Whitworth, E Rehmus, William Audeh, B Mavromatis, LL Lee, Ian Grady
Publikováno v:
Cancer Research. 79:OT1-13
BACKGROUND: Genomic signatures are revolutionizing the definition, identification, and treatment of breast cancer subtypes. The ability of genomic signatures to enable fine grained stratification of breast cancers to the granular disease level is sti
Autor:
Shirley Park, Billie R. Ocampo, Matt Kaeberlein, Sang Chul Park, Shiwen Chen, Young Wan Ha, Ryan Rossner, Yun-ll Lee, Christopher F. Bennett, Jeehae Han, Haeri Choi, Jong-Sun Kang, Sung Chun Cho
Publikováno v:
Translational Medicine of Aging, Vol 3, Iss, Pp 64-69 (2019)
The antibiotic diaminodiphenyl sulfone (DDS) is used in combination with other antibiotics as a first line treatment for leprosy. DDS has been previously reported to extend lifespan in Caenorhabditis elegans through inhibition of pyruvate kinase and
Publikováno v:
Dyes and Pigments. 160:936-943
Au/Cu2O/TiO2 core-shell nanorods are successfully synthesized using a facile three-step chemical synthesis technique. The Au nanoparticles core of Au/Cu2O performed as the catalytic activity enhancer, the Cu2O shell acts as a co-catalyst. The Au/Cu2O
Autor:
Rakesh Patel, Gia Compagnoni, Barry P. Rosen, Peter D. Beitsch, Y Robertson, D Rock, S Schonholz, LL Lee, P Whitworth, Antonio Carlos Sánchez Ruiz, Ian Grady, Karen Barbosa, P Baron
Publikováno v:
Cancer Research. 78:P4-06
This abstract was not presented at the symposium.
Autor:
Peter D. Beitsch, Lisette Stork-Sloots, James Pellicane, Charles Nash, F de Snoo, Carrie L. Dul, P Baron, Paul Richards, Angela Mislowsky, Mary Murray, Stephanie Akbari, Mark A. Gittleman, Jennifer Beatty, P Whitworth, LL Lee, Michael Rotkis, Sarah Untch
Publikováno v:
Cancer Research. 76:P1-14
Background Ideally classification by subtype predicts treatment response and overall outcome. BluePrint 80-gene functional molecular subtype is based on mRNA expression (as is intrinsic subtype) associated with intact translation to protein (unlike i
Autor:
B Peter, Lisette Stork-Sloots, F de Snoo, B Paul, B Jennifer, Angela Mislowsky, Stephanie Akbari, Mark A. Gittleman, Carrie L. Dul, Paul Richards, James Pellicane, Mary Murray, Charles Nash, Sarah Untch, W Pat, LL Lee, Michael Rotkis
Publikováno v:
Cancer Research. 76:P4-14
Background The prospective Neo-adjuvant Breast Registry Symphony Trial (NBRST) enrolled over 1000 US patients between June 2011 and December 2014. The aim of NBRST study is to compare chemosensitivity as defined by pathological Complete Response (pCR
Autor:
Stephanie Akbari, James Pellicane, Paul Richards, Lisette Stork-Sloots, Mark A. Gittleman, LL Lee, Jennifer Beatty, F de Snoo, P Whitworth, Michael Rotkis, Angela Mislowsky, Charles Nash, P Baron, Mary Murray, Peter D. Beitsch, Sarah Untch, Carrie L. Dul
Publikováno v:
Cancer Research. 76:P4-14
Background The phase 4 Neo-adjuvant Breast Registry Symphony Trial (NBRST) enrolled over 1,000 US patients between June 2011 and December 2014. The aim of NBRST study is to compare chemo-sensitivity as defined by pathological Complete Response (pCR)